BioCardia, Inc.
BCDA
$0.83
-$0.05-6.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.34% | -3.55% | -10.59% | -2.75% | 18.83% |
| Total Depreciation and Amortization | -75.00% | -64.18% | -50.00% | -37.66% | -25.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.62% | -21.36% | -2.04% | -1.12% | -6.26% |
| Change in Net Operating Assets | 30.49% | 86.04% | 110.08% | -428.11% | -4,855.56% |
| Cash from Operations | 6.23% | 5.71% | -0.93% | -16.97% | 10.85% |
| Capital Expenditure | -66.67% | -16.67% | 60.00% | -33.33% | -200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -66.67% | -16.67% | 60.00% | -33.33% | -200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.35% | -17.60% | -26.39% | 92.38% | 65.74% |
| Repurchase of Common Stock | -40.71% | -40.71% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.24% | 25.72% | 41.03% | -113.61% | -105.94% |
| Cash from Financing | -6.15% | -17.38% | -25.69% | 86.41% | 58.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -90.14% | -88.47% | 84.71% | 100.00% |